DoD Breast Cancer Era of Hope Scholar Award | HT942525BCRPEOHS

Opportunity Information: Apply for HT942525BCRPEOHS

The DoD Breast Cancer Era of Hope Scholar Award (FY25), administered by the U.S. Army Medical Research Acquisition Activity (USAMRAA) under the Breast Cancer Research Program (BCRP), is a discretionary federal grant designed to support early-career investigators who have already shown unusual promise and who are positioned to make a real, lasting impact on breast cancer research. The emphasis is intentionally placed on the person rather than on a single narrowly defined project. In other words, the program is looking for investigators with a track record of creative, high-impact thinking and the potential to become influential leaders in the field, not just a well-written proposal.

A central goal of the award is to identify "best and brightest" scientists who consistently go beyond conventional approaches and who can introduce fresh, innovative directions that could help end breast cancer. Applicants are expected to demonstrate not only scientific excellence but also the ability to build effective partnerships and collaborations, reflecting the program's interest in researchers who can connect disciplines, bring teams together, and accelerate progress through cooperative work. While the award recognizes the investigator, applications are still expected to align with the FY25 BCRP overarching challenges, unless the applicant provides a strong and convincing justification for why an exception is warranted.

Two notable program requirements set expectations for commitment and engagement. First, the Principal Investigator must dedicate at least 25 percent level of time and effort throughout the award period to conducting breast cancer research supported by this funding, signaling that the scholar is expected to be deeply involved rather than overseeing the work at a distance. Second, the research team must include two or more breast cancer consumer advocates, reinforcing the DoD BCRP tradition of incorporating the patient and survivor perspective directly into the research process to improve relevance, accountability, and real-world impact.

This opportunity (Funding Opportunity Number HT942525BCRPEOHS) falls under the Science and Technology/Research and Development activity category and is associated with CFDA number 12.420. Eligibility is listed as unrestricted, suggesting a broad applicant pool. The original application closing date is June 27, 2025. The agency anticipates making about two awards, and the award ceiling is not specified in the provided listing. Overall, the Era of Hope Scholar Award is best understood as a highly selective career-accelerating mechanism intended to elevate exceptional early-career leaders whose creativity, collaborative strength, and commitment can shift the trajectory of breast cancer research.

• The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Breast Cancer Era of Hope Scholar Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on 2025-04-22.
• Applicants must submit their applications by 2025-06-27. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 2 candidate(s).
• Eligible applicants include: Unrestricted.

Apply for HT942525BCRPEOHS

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: